Skip to content

Effect of garlic on patients with Non-Alcoholic Fatty Liver Disease

Effect of garlic on liver function, sonographic findings and body composition in patients with Non-Alcoholic Fatty Liver Disease

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2014110819853N1
Enrollment
100
Registered
2014-12-18
Start date
2014-11-22
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

non-alcoholic fatty liver disease. Fatty (change of) liver, not elsewhere classified

Interventions

Intervention 1: Intervention group: Garlic Tab 400 mg 2 times in day for 15 weeks (each tablet contains 1500 microgram allicin). Intervention 2: Control groups: tablet of starch? 2 times per day for 1
Treatment - Drugs
Placebo
Intervention group: Garlic Tab 400 mg 2 times in day for 15 weeks (each tablet contains 1500 microgram allicin)
Control groups: tablet of starch? 2 times per day for 15 weeks

Sponsors

Isfahan University Of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 60 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria :60> age >20;serum level of alanin aminotranspherase and aspartat aminotranspherase more than 40; fatty liver on ultra sound. exclusion criteria : pregnancy; breast feeding; alcohol; other liver diseases; diet or treatment for fatty liver in 3 month past; autoimmune diseases and cancers.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
ALT. Timepoint: before and 15 weeks after intervention. Method of measurement: photometric.;AST. Timepoint: before and 15 weeks after intervention. Method of measurement: photometric.;The severity of fatty liver. Timepoint: before and 15 weeks after intervention. Method of measurement: ultrasound.

Secondary

MeasureTime frame
Body composition. Timepoint: befor and 3 month of intervention. Method of measurement: instrument body composition.;FBS. Timepoint: befor and 3 month of intervention. Method of measurement: photometric.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactPaknahad

Isfahan University of Medical Sciences

paknahad@hlth.mui.ac.ir+98 31 3792 2784

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026